| |
| |
|
| Insider
Information: |
Gengos Andrew |
| Relationship: |
|
| City: |
Woodland Hills |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
498,671 |
|
|
Indirect Shares
|
47,000 |
|
|
| Direct
Value |
$232,313 |
|
|
|
Indirect Value
|
$1,410 |
|
|
| Total
Shares |
545,671 |
|
|
| Total
Value |
$233,723 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
ImmunoCellular Therapeutics Ltd |
IMUC |
President and CEO, Dir... |
2016-03-11 |
341,333 |
2016-03-11 |
47,000 |
Premium* |
|
|
Cyteir Therapeutics, Inc. |
CYT |
Officer |
2021-06-17 |
73,534 |
|
0 |
Premium* |
|
|
Athira Pharma, Inc. |
ATHA |
|
2024-01-05 |
83,804 |
2023-06-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATHA |
Athira Pharma, Inc. |
CFO AND CHIEF BUSINESS OFFICER |
• – – |
2024-01-05 |
4/A |
S |
$2.91 |
$3,515 |
D/D |
(1,208) |
83,804 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
CFO AND CHIEF BUSINESS OFFICER |
• – – |
2024-01-04 |
4/A |
A |
$0.00 |
$0 |
D/D |
5,000 |
85,012 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
See Below |
• – – |
2023-06-07 |
4 |
B |
$3.36 |
$51,445 |
D/D |
15,000 |
80,012 |
2.74 |
- |
|
| ATHA |
Athira Pharma, Inc. |
See Below |
• – – |
2023-06-05 |
4 |
B |
$3.00 |
$135,150 |
D/D |
45,000 |
65,012 |
2.74 |
- |
|
| ATHA |
Athira Pharma, Inc. |
See Below |
• – – |
2023-06-02 |
4 |
B |
$2.75 |
$56,422 |
D/D |
20,012 |
20,012 |
2.74 |
- |
|
| ATHA |
Athira Pharma, Inc. |
See Below |
• – – |
2023-01-05 |
4 |
S |
$2.91 |
$3,515 |
D/D |
(1,208) |
83,804 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
See Below |
• – – |
2023-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
85,012 |
0 |
- |
|
| CYT |
Cyteir Therapeutics, Inc. |
Chief Business OfficerOfficer |
• – – |
2021-06-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
73,534 |
|
- |
|
| IMUC |
ImmunoCellular Therapeuti... |
President and CEO |
• • – |
2016-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
341,333 |
0 |
- |
|
| IMUC |
ImmunoCellular Therapeuti... |
President and CEO |
• • – |
2015-11-30 |
4 |
B |
$0.44 |
$4,350 |
I/I |
10,000 |
47,000 |
2.58 |
- |
|
| IMUC |
ImmunoCellular Therapeuti... |
President and CEO |
• • – |
2015-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
228,333 |
0 |
- |
|
| IMUC |
ImmunoCellular Therapeuti... |
President and CEO |
• • – |
2015-02-18 |
4 |
B |
$0.60 |
$24,800 |
D/D |
41,333 |
78,333 |
2.81 |
- |
|
| IMUC |
ImmunoCellular Therapeuti... |
President and CEO |
• • – |
2014-08-14 |
4 |
B |
$0.90 |
$8,994 |
D/D |
10,000 |
37,000 |
2.81 |
- |
|
| IMUC |
ImmunoCellular Therapeuti... |
President and CEO |
• • – |
2013-12-18 |
4 |
B |
$0.72 |
$19,362 |
D/D |
27,000 |
27,000 |
2.81 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
